A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...